4.7 Article

Hypothalamic JNK1-hepatic fatty acid synthase axis mediates a metabolic rewiring that prevents hepatic steatosis in male mice treated with olanzapine via intraperitoneal: Additional effects of PTP1B inhibition

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Effects of the second-generation antipsychotic drugs aripiprazole and olanzapine on human adipocyte differentiation

Milica Vranic et al.

Summary: We investigated the effects of second-generation antipsychotics (SGAs) on adipocyte differentiation and metabolism and found that aripiprazole (ARI) can impair adipocyte glucose uptake and increase fatty acid oxidation gene expression, while olanzapine (OLA) can increase leptin gene expression. These findings have important implications for understanding the metabolic effects of antipsychotic drugs and suggest that different SGAs may have different mechanisms of action.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2023)

Article Food Science & Technology

Olanzapine-induced nonalcoholic fatty liver disease: The effects of differential food pattern and the involvement of PGRMC1 signaling

ZhenYu Zhu et al.

Summary: Detrimental dietary habits with high-fat food are common in the psychiatric population, leading to higher obesity rate. Olanzapine shows superior efficacy in schizophrenia treatment but is limited by adverse effects such as obesity, dyslipidemia, and liver injury. This study aims to investigate the role of PGRMC1 pathway in worsened nonalcoholic fatty liver disease (NAFLD) induced by high-fat supplementation and to explore PGRMC1 as a potential therapeutic target.

FOOD AND CHEMICAL TOXICOLOGY (2023)

Article Clinical Neurology

Proinflammatory biomarkers are associated with prediabetes in patients with schizophrenia

Marco Moller et al.

Summary: The study aimed to evaluate the relationship between the therapeutic effects of glucagon-like peptide-1 receptor agonist liraglutide and cytokines. The results showed that prediabetic patients treated with clozapine or olanzapine had increased levels of inflammatory cytokines in their serum, further confirming the link between inflammation and type 2 diabetes. However, treatment with liraglutide did not affect these cytokines.

CNS SPECTRUMS (2022)

Article Endocrinology & Metabolism

The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice

Diana Grajales et al.

Summary: Both olanzapine and aripiprazole induced adverse effects on beta cell function in female mice, leading to weight gain, glucose intolerance, and impaired insulin secretion. Aripiprazole had a stronger impact on metabolic alterations, likely due to its modulation of the serotonergic system.

DIABETOLOGIA (2022)

Article Biochemistry & Molecular Biology

HMDB 5.0: the Human Metabolome Database for 2022

David S. Wishart et al.

Summary: The Human Metabolome Database (HMDB) has been providing comprehensive information about human metabolites since 2007, and has undergone significant improvements and upgrades in its latest update, HMDB 5.0. These improvements include an increase in the number of metabolite entries, enhancements to metabolite descriptions, new visualization tools, and more accurately predicted spectral data sets. These upgrades are aimed at improving the usability and potential applications of the HMDB in various fields, including human metabolomics, exposomics, lipidomics, nutritional science, biochemistry, and clinical chemistry.

NUCLEIC ACIDS RESEARCH (2022)

Review Endocrinology & Metabolism

Neuronal regulation of glucagon secretion and gluconeogenesis

Bernard Thorens

Summary: Hypoglycemia rarely occurs in healthy individuals due to the presence of multiple sensing systems that trigger a counterregulatory hormonal response. However, this response is deregulated in diabetes patients receiving insulin therapy, increasing the risk of hypoglycemic episodes. Recent studies have focused on understanding how the central nervous system detects and restores normoglycemia in response to hypoglycemia.

JOURNAL OF DIABETES INVESTIGATION (2022)

Article Biochemistry & Molecular Biology

Gene expression changes following chronic antipsychotic exposure in single cells from mouse striatum

Anthony Abrantes et al.

Summary: This study utilized single-cell RNA-sequencing to explore the impact of antipsychotic drugs on gene expression, revealing differences in gene expression profiles between different medications, particularly in medium spiny neurons; analysis of gene expression also identified genes associated with schizophrenia; the findings highlighted the involvement of pathways related to neuron development, alternative splicing, and mitochondrial function in antipsychotic action.

MOLECULAR PSYCHIATRY (2022)

Article Neurosciences

Chronic oral olanzapine treatment but not haloperidol decreases [3H] MK-801 binding in the rat brain Independent of dietary conditions

Leah Waldman et al.

Summary: Olanzapine treatment significantly decreases NMDAR expression in certain brain regions, while haloperidol treatment and a high-fat diet have no effect on NMDAR expression.

NEUROSCIENCE LETTERS (2022)

Article Multidisciplinary Sciences

Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway

Wenqiang Zhu et al.

Summary: This study found that olanzapine, a drug commonly used to treat schizophrenia, can cause non-alcoholic fatty liver disease (NAFLD) by upregulating PCSK9 through LXR alpha. Metformin was shown to ameliorate the pathological alterations associated with olanzapine-induced NAFLD.

SCIENTIFIC REPORTS (2022)

Article Nutrition & Dietetics

Paeoniflorin Rescued MK-801-Induced Schizophrenia-Like Behaviors in Mice via Oxidative Stress Pathway

Jia-Quan Liang et al.

Summary: The study demonstrates that paeoniflorin can alleviate schizophrenia-like behaviors through inhibiting the oxidative stress pathway. The potential mechanisms of restoring neuronal expression and preventing neurotoxicity were also revealed.

FRONTIERS IN NUTRITION (2022)

Article Endocrinology & Metabolism

Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight

Vitor Ferreira et al.

Summary: This study evaluated the effects of olanzapine on body weight and energy balance in mice and proposed a new perspective on the crosstalk between the hypothalamus and adipose tissue. The results showed that activation of hypothalamic AMPK can prevent olanzapine-induced weight gain by promoting BAT thermogenesis and iWAT browning.

METABOLISM-CLINICAL AND EXPERIMENTAL (2022)

Review Medicine, Research & Experimental

Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease

Jiashu Pan et al.

Summary: This study summarizes the pathogenesis of nonalcoholic fatty liver disease (NAFLD) and the urgent need for approved treatment. It highlights the important role of peroxisome proliferator activated receptors (PPARs) in regulating NAFLD and summarizes natural products that target PPARs to treat NAFLD.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Endocrinology & Metabolism

Protein Tyrosine Phosphatase 1B Deficiency Improves Glucose Homeostasis in Type 1 Diabetes Treated With Leptin

Yoshihiro Ito et al.

Summary: Leptin shows potential therapeutic effects for T1D, and PTP1B is a key enzyme that negatively regulates leptin receptor signaling. The study found that PTP1B deficiency or combined treatment with leptin and a PTP1B inhibitor can enhance leptin activity and improve glucose metabolism in T1D mice.

DIABETES (2022)

Article Multidisciplinary Sciences

Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease

Partho Sen et al.

Summary: This study investigated the metabolic pathways of nonalcoholic fatty liver disease (NAFLD) and identified metabolic signatures in the liver and blood that are associated with its progression.

ISCIENCE (2022)

Review Medicine, Research & Experimental

Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders

Jordi Olloquequi et al.

Summary: PTP1B is a potential target for the treatment of neurological diseases, as its activation in brain cells can lead to various neuronal deficits. However, inhibition of PTP1B has shown promising therapeutic effects and potential to improve cognitive processes. Clinical trials evaluating the neurological benefits of PTP1B inhibition are still needed.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Pharmacology & Pharmacy

Metformin ameliorates olanzapine-induced obesity and glucose intolerance by regulating hypothalamic inflammation and microglial activation in female mice

Sang Bum Suh et al.

Summary: The study found that olanzapine can induce metabolic disorders mainly by activating and inflaming hypothalamic microglia, with the application of metformin alleviating this inflammation and preventing metabolic disorders. Female mice are more susceptible to the metabolic side effects of olanzapine.

FRONTIERS IN PHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

Safety of Intravenous Olanzapine Administration at a Tertiary Academic Medical Center

Nicholas F. Hunt et al.

Summary: This study evaluated the safety of intravenous push olanzapine administration in inpatient settings, finding hypotension to be the most commonly noted adverse drug event, occurring more frequently than in previous studies. Intravenous push olanzapine appears to be a safe route of administration in hospitalized patients, including those receiving multiple doses.

ANNALS OF PHARMACOTHERAPY (2021)

Article Multidisciplinary Sciences

Olanzapine induced reproductive toxicity in male rats

Cankiz Mina Ardic et al.

Summary: The research revealed that olanzapine had toxic effects on the reproductive system of rats, causing abnormalities in testicular structure, decreased normal sperm morphology, alterations in hormone levels, and oxidative stress in the testis.

SCIENTIFIC REPORTS (2021)

Article Pharmacology & Pharmacy

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease

Yuting Ma et al.

Summary: Empagliflozin, a novel type of sodium-glucose cotransporter two inhibitor, has diverse beneficial effects in the treatment of nonalcoholic fatty liver disease (NAFLD) by regulating lipid metabolism. This study identified key pathways affected by empagliflozin in a mouse model of NAFLD, showing improved lipid synthesis and metabolism. The experiment provides robust evidence on the impact of empagliflozin on NAFLD through enhanced triglyceride transfer, triglyceride lipolysis, and microsomal mitochondrial beta-oxidation.

FRONTIERS IN PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

Effect of Central Corticotropin-Releasing Factor on Hepatic Lipid Metabolism and Inflammation-Related Gene Expression in Rats

Yukiomi Nakade et al.

Summary: The study showed that central corticotropin-releasing factor (CRF) affects hepatic de novo lipogenesis and inflammation-related gene expression in rats through the sympathetic-noradrenergic nervous system.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic liver disease

Hong Yang et al.

Summary: Researchers conducted network analysis and integrative systems analysis to reveal key transcriptional regulators and biological processes involved in the progression of NAFLD, enhancing the understanding of the disease mechanism.

ISCIENCE (2021)

Article Neurosciences

Ketamine's schizophrenia-like effects are prevented by targeting PTP1B

Zhaohong Qin et al.

Summary: Ketamine induces schizophrenia-like behaviors in mice and affects synaptic transmission onto pyramidal neurons in the prefrontal cortex. Inhibition of PTP1B restores neuronal properties and prevents ketamine-induced deficits, suggesting potential for PTP1B inhibitors as antipsychotic drugs. The study highlights the role of PTP1B in different cell types in mediating various effects of ketamine.

NEUROBIOLOGY OF DISEASE (2021)

Article Medicine, Research & Experimental

Olanzapine leads to nonalcoholic fatty liver disease through the apolipoprotein A5 pathway

Rong Li et al.

Summary: Olanzapine can induce nonalcoholic fatty liver disease (NAFLD), where the mechanism involves factors such as apoA5 and sortilin. Sortilin inhibits hepatic apoA5 secretion, contributing to the development of NAFLD caused by olanzapine.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Biochemical Research Methods

rMSIproc: an R package for mass spectrometry imaging data processing

Pere Rafols et al.

BIOINFORMATICS (2020)

Article Gastroenterology & Hepatology

Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease

Anand R. Saran et al.

GASTROENTEROLOGY (2020)

Review Immunology

Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation

Ariane R. Pessentheiner et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Biochemical Research Methods

Detecting Oxidative Stress Biomarkers in Neurodegenerative Disease Models and Patients

Yulia Sidorova et al.

METHODS AND PROTOCOLS (2020)

Article Multidisciplinary Sciences

N-acetylcysteine prevents olanzapine-induced oxidative stress in mHypoA-59 hypothalamic neurons

Zehra Boz et al.

SCIENTIFIC REPORTS (2020)

Article Gastroenterology & Hepatology

Psychotropic Medications Are Associated With Increased Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease

Marialena Mouzaki et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)

Article Biochemistry & Molecular Biology

WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs

Yuxing Liao et al.

NUCLEIC ACIDS RESEARCH (2019)

Review Physiology

Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease

Dongmei Shi et al.

FRONTIERS IN PHYSIOLOGY (2019)

Article Food Science & Technology

Antioxidant Profile of 1-Monocaffeoyl Glycerol in Lipophobic/Lipophilic Media

Longmei Weng et al.

JOURNAL OF FOOD SCIENCE (2019)

Article Biochemistry & Molecular Biology

Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases

Inmaculada Garcia-Ruiz et al.

REDOX BIOLOGY (2019)

Review Clinical Neurology

Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review

Haiyun Xu et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2019)

Article Chemistry, Analytical

LipSpin: A New Bioinformatics Tool for Quantitative H-1 NMR Lipid Profiling

Ruben Barrilero et al.

ANALYTICAL CHEMISTRY (2018)

Article Clinical Neurology

Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies

Kyle J. Burghardt et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)

Article Biochemistry & Molecular Biology

Omega-6 fatty acids and inflammation

Jacqueline K. Innes et al.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2018)

Review Neurosciences

Effect of Chronic Oxidative Stress on Neuroinflammatory Response Mediated by CD4+T Cells in Neurodegenerative Diseases

Helena Solleiro-Villavicencio et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2018)

Article Medicine, Research & Experimental

Macrophage migration inhibitory factor mediates metabolic dysfunction induced by atypical antipsychotic therapy

Donghong Cui et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Cell Biology

Omega-9 Oleic Acid, the Main Compound of Olive Oil, Mitigates Inflammation during Experimental Sepsis

Isabel Matos Medeiros-de-Moraes et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)

Editorial Material Cell Biology

Oxidative Stress and Inflammation in Hepatic Diseases: Current and Future Therapy

Karina Reyes-Gordillo et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)

Review Pharmacology & Pharmacy

Oxidative Stress and the Central Nervous System

Samina Salim

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)

Review Psychiatry

Guidelines for the Pharmacotherapy of Schizophrenia in Adults

Gary Remington et al.

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2017)

Article Biochemical Research Methods

rMSI: an R package for MS imaging data handling and visualization

Pere Rafols et al.

BIOINFORMATICS (2017)

Review Biochemistry & Molecular Biology

PPARs and nonalcoholic fatty liver disease

Kim H. H. Liss et al.

BIOCHIMIE (2017)

Article Medicine, Research & Experimental

Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models

Francis Fregonesi Brinholi et al.

BIOMEDICINE & PHARMACOTHERAPY (2016)

Article Immunology

A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation

Gyun Jee Song et al.

JOURNAL OF NEUROINFLAMMATION (2016)

Article Biotechnology & Applied Microbiology

Near-optimal probabilistic RNA-seq quantification

Nicolas L. Bray et al.

NATURE BIOTECHNOLOGY (2016)

Review Gastroenterology & Hepatology

Nonalcoholic fatty liver disease - A multisystem disease?

Ivana Mikolasevic et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Article Clinical Neurology

Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses

Marie-Caroline Cotel et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)

Article Clinical Neurology

Olanzapine depot exposure in male rats: Dose-dependent lipogenic effects without concomitant weight gain

J. Ferno et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)

Article Food Science & Technology

Resveratrol treatment restores peripheral insulin sensitivity in diabetic mice in a sirt1-independent manner

Agueda Gonzalez-Rodriguez et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2015)

Article Biochemical Research Methods

Dolphin: a tool for automatic targeted metabolite profiling using 1D and 2D 1H-NMR data

Josep Gomez et al.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2014)

Article Cell Biology

Estradiol Regulates Brown Adipose Tissue Thermogenesis via Hypothalamic AMPK

Pablo B. Martinez de Morentin et al.

CELL METABOLISM (2014)

Review Immunology

Inflammation in neurodegenerative diseases-an update

Sandra Amor et al.

IMMUNOLOGY (2014)

Article Clinical Neurology

Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects

Silje Skrede et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)

Article Clinical Neurology

Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats

H. N. Boyda et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)

Article Multidisciplinary Sciences

The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse

Andrew P. Morgan et al.

PLOS ONE (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Behavioral Sciences

Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophrenia

Tomiki Sumiyoshi et al.

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2013)

Article Biochemistry & Molecular Biology

The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma

Lars Lofgren et al.

JOURNAL OF LIPID RESEARCH (2012)

Article Biochemistry & Molecular Biology

The Oxidative Stress May be Induced by the Elevated Homocysteine in Schizophrenic Patients

Anna Dietrich-Muszalska et al.

NEUROCHEMICAL RESEARCH (2012)

Article Biochemistry & Molecular Biology

Creatine as an antioxidant

Piero Sestili et al.

AMINO ACIDS (2011)

Review Pharmacology & Pharmacy

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011

C. Hiemke et al.

PHARMACOPSYCHIATRY (2011)

Article Endocrinology & Metabolism

Inhibition of PTP1B Restores IRS1-Mediated Hepatic Insulin Signaling in IRS2-Deficient Mice

Agueda Gonzalez-Rodriguez et al.

DIABETES (2010)

Article Clinical Neurology

Effects of antipsychotics and vitamin C on the formation of reactive oxygen species

P. Heiser et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2010)

Article Biochemistry & Molecular Biology

Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance

Miguel Lopez et al.

NATURE MEDICINE (2010)

Review Biochemistry & Molecular Biology

Biosynthesis and bioavailability of long-chain polyunsaturated fatty acids in non-alcoholic fatty liver disease

Juan G. Gormaz et al.

PROGRESS IN LIPID RESEARCH (2010)

Review Clinical Neurology

A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model

Heidi N. Boyda et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)

Article Medicine, General & Internal

Choline supplementation reduces oxidative stress in mouse model of allergic airway disease

A. K. Mehta et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)

Article Gastroenterology & Hepatology

Inhibiting Glycosphingolipid Synthesis Ameliorates Hepatic Steatosis in Obese Mice

Hongmei Zhao et al.

HEPATOLOGY (2009)

Article Neurosciences

Oxidative/Nitrative Modifications of Plasma Proteins and Thiols from Patients with Schizophrenia

Anna Dietrich-Muszalska et al.

NEUROPSYCHOBIOLOGY (2009)

Review Psychiatry

Secondary Effects of Antipsychotics: Women at Greater Risk Than Men

Mary V. Seeman

SCHIZOPHRENIA BULLETIN (2009)

Article Biochemistry & Molecular Biology

Antioxidant Combination Inhibits Reactive Oxygen Species Mediated Damage

Nobuya Yanai et al.

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2008)

Article Medical Laboratory Technology

Large intraindividual variability of olanzapine serum concentrations in adolescent patients

Christian J. Bachmann et al.

THERAPEUTIC DRUG MONITORING (2008)

Article Endocrinology & Metabolism

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders

D Cohen et al.

DIABETES CARE (2006)

Article Endocrinology & Metabolism

Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents

Vance L. Albaugh et al.

OBESITY (2006)

Article Biochemistry & Molecular Biology

Antioxidant action of L-alanine:: heme oxygenase-1 and ferritin as possible mediators

N Grosser et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)

Article Medicine, Research & Experimental

Polyunsaturated fatty acids and inflammatory diseases

A Gil

BIOMEDICINE & PHARMACOTHERAPY (2002)

Article Medicine, Research & Experimental

Sphingomyelin: a natural modulator of membrane homeostasis and inflammation

PV Subbaiah et al.

MEDICAL HYPOTHESES (2001)